138 related articles for article (PubMed ID: 21070606)
1. L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation.
Carlson MJ; Fulton LM; Coghill JM; West ML; Burgents JE; Wan Y; Panoskaltsis-Mortari A; Tedder TF; Blazar BR; Serody JS
Am J Transplant; 2010 Dec; 10(12):2596-603. PubMed ID: 21070606
[TBL] [Abstract][Full Text] [Related]
2. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.
Ermann J; Hoffmann P; Edinger M; Dutt S; Blankenberg FG; Higgins JP; Negrin RS; Fathman CG; Strober S
Blood; 2005 Mar; 105(5):2220-6. PubMed ID: 15546950
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
4. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.
Wysocki CA; Jiang Q; Panoskaltsis-Mortari A; Taylor PA; McKinnon KP; Su L; Blazar BR; Serody JS
Blood; 2005 Nov; 106(9):3300-7. PubMed ID: 16002422
[TBL] [Abstract][Full Text] [Related]
5. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
[TBL] [Abstract][Full Text] [Related]
6. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.
Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ
Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure.
Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U
Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
[TBL] [Abstract][Full Text] [Related]
9. Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease.
Florek M; Schneidawind D; Pierini A; Baker J; Armstrong R; Pan Y; Leveson-Gower D; Negrin R; Meyer E
PLoS One; 2015; 10(12):e0145763. PubMed ID: 26693907
[TBL] [Abstract][Full Text] [Related]
10. SHIP limits immunoregulatory capacity in the T-cell compartment.
Collazo MM; Wood D; Paraiso KH; Lund E; Engelman RW; Le CT; Stauch D; Kotsch K; Kerr WG
Blood; 2009 Mar; 113(13):2934-44. PubMed ID: 19136659
[TBL] [Abstract][Full Text] [Related]
11. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.
Taylor PA; Panoskaltsis-Mortari A; Swedin JM; Lucas PJ; Gress RE; Levine BL; June CH; Serody JS; Blazar BR
Blood; 2004 Dec; 104(12):3804-12. PubMed ID: 15292057
[TBL] [Abstract][Full Text] [Related]
12. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
Scalapino KJ; Daikh DI
PLoS One; 2009 Jun; 4(6):e6031. PubMed ID: 19551149
[TBL] [Abstract][Full Text] [Related]
13. Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.
Vogtenhuber C; Bucher C; Highfill SL; Koch LK; Goren E; Panoskaltsis-Mortari A; Taylor PA; Farrar MA; Blazar BR
Blood; 2010 Jul; 116(3):466-74. PubMed ID: 20442366
[TBL] [Abstract][Full Text] [Related]
14. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.
Chen BJ; Cui X; Sempowski GD; Liu C; Chao NJ
Blood; 2004 Feb; 103(4):1534-41. PubMed ID: 14551132
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.
Sato K; Eizumi K; Fukaya T; Fujita S; Sato Y; Takagi H; Yamamoto M; Yamashita N; Hijikata A; Kitamura H; Ohara O; Yamasaki S; Saito T; Sato K
Blood; 2009 May; 113(19):4780-9. PubMed ID: 19228924
[TBL] [Abstract][Full Text] [Related]
16. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
Lu SX; Kappel LW; Charbonneau-Allard AM; Atallah R; Holland AM; Turbide C; Hubbard VM; Rotolo JA; Smith M; Suh D; King C; Rao UK; Yim N; Bautista JL; Jenq RR; Penack O; Na IK; Liu C; Murphy G; Alpdogan O; Blumberg RS; Macian F; Holmes KV; Beauchemin N; van den Brink MR
PLoS One; 2011; 6(7):e21611. PubMed ID: 21760897
[TBL] [Abstract][Full Text] [Related]
17. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.
Szanya V; Ermann J; Taylor C; Holness C; Fathman CG
J Immunol; 2002 Sep; 169(5):2461-5. PubMed ID: 12193715
[TBL] [Abstract][Full Text] [Related]
18. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
Scalapino KJ; Tang Q; Bluestone JA; Bonyhadi ML; Daikh DI
J Immunol; 2006 Aug; 177(3):1451-9. PubMed ID: 16849451
[TBL] [Abstract][Full Text] [Related]
19. IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy.
Yarkoni S; Prigozhina TB; Slavin S; Askenasy N
Biol Blood Marrow Transplant; 2012 Apr; 18(4):523-35. PubMed ID: 22227590
[TBL] [Abstract][Full Text] [Related]
20. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation.
Vela-Ojeda J; Montiel-Cervantes L; Granados-Lara P; Reyes-Maldonado E; García-Latorre E; Garcia-Chavez J; Majluf-Cruz A; Mayani H; Borbolla-Escoboza JR; Esparza MG
Stem Cells Dev; 2010 Mar; 19(3):333-40. PubMed ID: 19919293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
